THC Biomed International Ltd
TFHD
Company Profile
Business description
THC Biomed International Ltd operates as a licensed producer under Canada's Marijuana for Medical Purposes Regulations (MMPR). It is also engaged in the research and development of the products and services to medical marihuana. In addition, it is also engaged in providing horticulture training, record keeping and documenting research studies, and analytical services. Geographically all the activities are carried out through the region of Canada.
Contact
Unit 1 - 2550 Acland Road
KelownaBCV1X 7L4
CANT: +1 250 870-2512
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 July 2025
Employees
35
Stocks News & Analysis
stocks
Our top ASX picks in every sector
These companies are our top choices for investors wanting to boost Aussie exposure.
stocks
Potentially catastrophic ruling for ASX company
We raise our risk and uncertainty rating to reflect the impact of the ruling.
stocks
4 charts on Nvidia’s record $4 trillion market cap
Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,867.20 | 51.90 | 0.59% |
| CAC 40 | 7,808.17 | 21.12 | -0.27% |
| DAX 40 | 24,160.64 | 94.67 | -0.39% |
| Dow JONES (US) | 44,459.65 | 88.14 | 0.20% |
| FTSE 100 | 8,998.06 | 56.94 | 0.64% |
| HKSE | 24,331.65 | 128.33 | 0.53% |
| NASDAQ | 20,640.33 | 54.80 | 0.27% |
| Nikkei 225 | 39,581.63 | 122.01 | 0.31% |
| NZX 50 Index | 12,689.63 | 10.94 | 0.09% |
| S&P 500 | 6,268.56 | 8.81 | 0.14% |
| S&P/ASX 200 | 8,623.40 | 53.00 | 0.62% |
| SSE Composite Index | 3,496.66 | 22.99 | -0.65% |